The overarching goal ofthe Physiology Phenotyping Core (PPC) is to promote the health and welfare of individuals with sensory and/or nervous system disorders by providing state-of-the-art core support that will facilitate the integration of physiological, molecular and genetic disciplines into a comprehensive biomedical research program. To achieve that goal, the PPC offers a broad range of sensory and neurophysiology services, including measurement of evoked near- and far-field potentials, otoacoustic emissions, single- and multi-neuron recordings, and micro-pharmacology support. PPC staff are available to participate actively in all aspects of data acquisition, data reduction, data analyses and reporting functions associated with each investigation. The specific goals of the PPC are to provide state-of-the-art technical, conceptual, and scientific support for investigators conducting sensory and neurophysiological studies, to develop and incorporate novel methodologies, such as optogenetic techniques, and to advise and mentor investigators in an effort to promote an interdisciplinary research environment and thereby enhance opportunities to successfully compete for research funding on a national scale. The PPC came into service in Phase II ofthe COBRE in response to demand associated with the successful creation of mouse models with genetic and/or molecular features with significant clinical implications. Moving into Phase III of operation, a fee structure for services has been developed to sustain the facility in the long term, and a high program priority is to expand the base of user support to include investigators on a statewide and regional basis and in doing so advance biomedical research initiatives aimed at understanding the function of normal and abnormal nervous and sensory systems.
Access to the research tools available in the Physiology Phenotyping Core is intended to broaden the regional biomedical research base by incorporating neurophysiological and sensory physiology techniques into an existing interdisciplinary neuroscience research program and by providing expert scientific and technical services to facility users wishing to study the physiology of animal models with significant nervous svstem and sensnrv health relevance.
|Ka, Minhan; Chopra, Divyan A; Dravid, Shashank M et al. (2016) Essential Roles for ARID1B in Dendritic Arborization and Spine Morphology of Developing Pyramidal Neurons. J Neurosci 36:2723-42|
|Dufek, Brianna; Meehan, Daniel T; Delimont, Duane et al. (2016) Endothelin A receptor activation on mesangial cellsÂ initiates Alport glomerular disease. Kidney Int 90:300-10|
|Gurumurthy, Channabasavaiah B; Takahashi, Gou; Wada, Kenta et al. (2016) GONAD: A Novel CRISPR/Cas9 Genome Editing Method that Does Not Require Ex Vivo Handling of Embryos. Curr Protoc Hum Genet 88:Unit 15.8|
|Ka, Minhan; Kim, Woo-Yang (2016) Microtubule-Actin Crosslinking Factor 1 Is Required for Dendritic Arborization and Axon Outgrowth in the Developing Brain. Mol Neurobiol 53:6018-6032|
|Yilmazer-Hanke, Deniz; O'Loughlin, Elaine; McDermott, Kieran (2016) Contribution of amygdala pathology to comorbid emotional disturbances in temporal lobe epilepsy. J Neurosci Res 94:486-503|
|Meehan, Daniel T; Delimont, Duane; Dufek, Brianna et al. (2016) Endothelin-1 mediated induction of extracellular matrix genes in strial marginal cells underlies strial pathology in Alport mice. Hear Res 341:100-108|
|Schulze, Thomas T; Ali, Jonathan M; Bartlett, Maggie L et al. (2016) De novo Assembly and Analysis of the Chilean Pencil Catfish Trichomycterus areolatus Transcriptome. J Genomics 4:29-41|
|Wong, Chuu-Yun A; Jiang, Haihong; Abel, Peter W et al. (2016) Phorbol myristate acetate suppresses breast cancer cell growth via down-regulation of P-Rex1 expression. Protein Cell 7:445-9|
|Sato, Masahiro; Ohtsuka, Masato; Watanabe, Satoshi et al. (2016) Nucleic acids delivery methods for genome editing in zygotes and embryos: the old, the new, and the old-new. Biol Direct 11:16|
|Kristensen, Anders S; Hansen, Kasper B; Naur, Peter et al. (2016) Pharmacology and Structural Analysis of Ligand Binding to the Orthosteric Site of Glutamate-Like GluD2 Receptors. Mol Pharmacol 89:253-62|
Showing the most recent 10 out of 45 publications